COVID-19 ELISA IgG DIATHEVA kit is a immunoenzymatic assay (ELISA) for the determination of IgM antibodies to the COVID-19 coronavirus Nucleocapisid (N) antigen from plasma and serum samples.
The kit is CE-IVD marked in compliance with 98/79/CE directive (IVDD).
Coronaviruses are a large family of viruses that are common in people and many different species of animals including camels, cattle, cats, and bats.
In December 2019, a cluster of patients with a novel coronavirus was identified in Wuhan, China. The virus named SARS-CoV-2 can cause the disease named coronavirus disease 2019 (COVID-2019) [WHO, 2 March 2020].
During virion assembly, N protein binds to viral RNA and leads to formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein implicated in viral genome replication and in modulating cell signaling pathways. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as an optimal diagnostic marker. Two types of antibodies against this virus (IgM and IgG) are produced and secreted into the circulation by the immune system. COVID-19 ELISA IgM DIATHEVA kit is a Immunoenzymic essay (ELISA) for the determination of IgM antibodies to the COVID-19 coronavirus Nucleocapsid (N). The kit is equipped with positive and negative synthetic controls as well as a control on the blank value.
| Size | 96 tests |
|---|---|
| Application | Clinical diagnostics |
| Product type | Diagnostic kit |
| Reagent type | ELISA |
| Category | COVID-19 |
| Size | 96 tests |
|---|---|
| Technology | Direct ELISA |
| Specimen | Human serum or plasma samples |
| Testing time | 140 minutes |
| Target gene | IgM antibodies |
